Traumatic brain injury dysregulates MicroRNAs to modulate cell signaling in rat hippocampus

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Liu, Liang ^a,b   Sun, Tingyi ^a   Liu, Zilong ^a   Chen, Xiaorui ^a   Zhao, Lili ^a   Qu, Guoqiang ^a   Li, Qingjie ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CHINA UNIVERSITY OF POLITICAL SCIENCE AND LAW   (China)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CALCIUM CALMODULIN DEPENDENT SERINE PROTEIN KINASE; MICRORNA; MIR 144; MIR 153; MIR 340 5P; PROTEIN SERINE KINASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; CASK KINASES; GUANYLATE KINASE; NFE2L2 PROTEIN, RAT; SNCA PROTEIN, RAT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HIPPOCAMPUS; HISTOPATHOLOGY; MICROARRAY ANALYSIS; NEUROPATHOLOGY; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYNAPSE; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING; ANIMAL; BRAIN INJURY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC EPIGENESIS; GENETICS; INJURIES; MALE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; SPRAGUE DAWLEY RAT; TIME; ULTRASTRUCTURE;

ALPHA-SYNUCLEIN; ANIMALS; APOPTOSIS; BRAIN INJURIES; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GUANYLATE KINASE; HIPPOCAMPUS; MALE; MICRORNAS; MOLECULAR SEQUENCE ANNOTATION; NF-E2-RELATED FACTOR 2; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SYNAPSES; TIME FACTORS;

EID: 84905451493     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103948     Document Type: Article

References (66)

1. Corrigan JD, Selassie AW, Orman JA (2010) The epidemiology of traumatic brain injury. J Head Trauma Rehabil 25: 72-80.
2. Feigin VL, Theadom A, Barker-Collo S, Starkey NJ, McPherson K, et al. (2013) Incidence of traumatic brain injury in New Zealand: a population-based study. Lancet Neurol 12: 53-64.
3. Menon DK, Schwab K, Wright DW, Maas AI (2010) Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil 91: 1637-1640.
4. Jennekens N, de Casterle BD, Dobbels F (2010) A systematic review of care needs of people with traumatic brain injury (TBI) on a cognitive, emotional and behavioural level. J Clin Nurs 19: 1198-1206.
5. Fanselow MS, Dong HW (2010) Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 65: 7-19.
6. Orrison WW, Hanson EH, Alamo T, Watson D, Sharma M, et al. (2009) Traumatic brain injury: a review and high-field MRI findings in 100 unarmed combatants using a literature-based checklist approach. J Neurotrauma 26: 689-701.
7. Berezikov E, Chung WJ, Willis J, Cuppen E, Lai EC (2007) Mammalian mirtron genes. Mol Cell 28: 328-336. (Pubitemid 47600007)
8. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114.
9. Fineberg SK, Kosik KS, Davidson BL (2009) MicroRNAs potentiate neural development. Neuron 64: 303-309.
10. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 105: 1608-1613. (Pubitemid 351346562)
11. Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318: 1931-1934.
12. Sassen S, Miska EA, Caldas C (2008) MicroRNA: implications for cancer. Virchows Arch 452: 1-10.
13. Bak M, Silahtaroglu A, Moller M, Christensen M, Rath MF, et al. (2008) MicroRNA expression in the adult mouse central nervous system. RNA 14: 432-444. (Pubitemid 351397808)
14. Krichevsky AM (2007) MicroRNA profiling: from dark matter to white matter, or identifying new players in neurobiology. ScientificWorldJournal 7: 155-166.
15. Hu Z, Yu D, Almeida-Suhett C, Tu K, Marini AM, et al. (2012) Expression of miRNAs and their cooperative regulation of the pathophysiology in traumatic brain injury. PLoS One 7: e39357.
16. Redell JB, Liu Y, Dash PK (2009) Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes. J Neurosci Res 87: 1435-1448.
17. Lighthall JW (1988) Controlled cortical impact: a new experimental brain injury model. J Neurotrauma 5: 1-15.
18. Chen S, Pickard JD, Harris NG (2003) Time course of cellular pathology after controlled cortical impact injury. Exp Neurol 182: 87-102. (Pubitemid 36776252)
19. Lei P, Li Y, Chen X, Yang S, Zhang J (2009) Microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury. Brain Res 1284: 191-201.
20. Zhang Y, Chopp M, Mahmood A, Meng Y, Qu C, et al. (2012) Impact of inhibition of erythropoietin treatment-mediated neurogenesis in the dentate gyrus of the hippocampus on restoration of spatial learning after traumatic brain injury. Exp Neurol 235: 336-344.
21. Calkins MJ, Johnson DA, Townsend JA, Vargas MR, Dowell JA, et al. (2009) The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal 11: 497-508.
22. Chen K, Featherstone DE (2011) Pre and postsynaptic roles for Drosophila CASK. Mol Cell Neurosci 48: 171-182.
23. Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, et al. (2004) Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55: 174-179. (Pubitemid 38166993)
24. Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, et al. (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65: 66-79.
25. van Muiswinkel FL, Kuiperij HB (2005) The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders. Curr Drug Targets CNS Neurol Disord 4: 267-281. (Pubitemid 40754162)
26. Persengiev S, Kondova I, Otting N, Koeppen AH, Bontrop RE (2011) Genomewide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis. Neurobiol Aging 32: 2316 e2317-2327.
27. Cheng C, Li W, Zhang Z, Yoshimura S, Hao Q, et al. (2013) MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10). J Biol Chem 288: 13748-13761.
28. Hata Y, Butz S, Sudhof TC (1996) CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins. J Neurosci 16: 2488-2494. (Pubitemid 26124345)
29. Hsueh YP, Yang FC, Kharazia V, Naisbitt S, Cohen AR, et al. (1998) Direct interaction of CASK/LIN-2 and syndecan heparan sulfate proteoglycan and their overlapping distribution in neuronal synapses. J Cell Biol 142: 139-151. (Pubitemid 28341146)
30. Hsueh YP, Sheng M (1999) Regulated expression and subcellular localization of syndecan heparan sulfate proteoglycans and the syndecan-binding protein CASK/LIN-2 during rat brain development. J Neurosci 19: 7415-7425.
31. Chao HW, Hong CJ, Huang TN, Lin YL, Hsueh YP (2008) SUMOylation of the MAGUK protein CASK regulates dendritic spinogenesis. J Cell Biol 182: 141-155.
32. Craig AM, Kang Y (2007) Neurexin-neuroligin signaling in synapse development. Curr Opin Neurobiol 17: 43-52. (Pubitemid 46227985)
33. Fairless R, Masius H, Rohlmann A, Heupel K, Ahmad M, et al. (2008) Polarized targeting of neurexins to synapses is regulated by their C-terminal sequences. J Neurosci 28: 12969-12981.
34. Jeyifous O, Waites CL, Specht CG, Fujisawa S, Schubert M, et al. (2009) SAP97 and CASK mediate sorting of NMDA receptors through a previously unknown secretory pathway. Nat Neurosci 12: 1011-1019.
35. Carasatorre M and Ramirez-Amaya V (2013) Network, cellular, and molecular mechanisms underlying long-term memory formation. Curr Top Behav Neurosci 15: 73-115.
36. Nistico R, Pignatelli M, Piccinin S, Mercuri NB, Collingridge G (2012) Targeting synaptic dysfunction in Alzheimer's disease therapy. Mol Neurobiol 46: 572-587.
37. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298: 789-791.
38. Li XH, Li CY, Lu JM, Tian RB, Wei J (2012) Allicin ameliorates cognitive deficits ageing-induced learning and memory deficits through enhancing of Nrf2 antioxidant signaling pathways. Neurosci Lett 514: 46-50.
39. Doxakis E (2010) Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 285: 12726-12734.
40. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, et al. (2003) alpha- Synuclein locus triplication causes Parkinson's disease. Science 302: 841. (Pubitemid 37339619)
41. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) alpha- Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 95: 6469-6473. (Pubitemid 28249037)
42. Liang C, Zhu H, Xu Y, Huang L, Ma C, et al. (2012) MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2. Brain Res 1455: 103-113.
43. Kim TH, Kim YK, Kwon Y, Heo JH, Kang H, et al. (2010) Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology 57: 734-743.
44. Xu J, Liao X, Lu N, Liu W, Wong CW (2011) Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines. Int J Cancer 129: 2527-2531.
45. Xu J, Liao X, Wong C (2010) Downregulations of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. Int J Cancer 126: 1029-1035.
46. Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, et al. (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 22: 8797-8807. (Pubitemid 35379049)
47. Clayton DF, George JM (1999) Synucleins in synaptic plasticity and neurodegenerative disorders. J Neurosci Res 58: 120-129. (Pubitemid 29463698)
48. Hsu LJ, Mallory M, Xia Y, Veinbergs I, Hashimoto M, et al. (1998) Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development. J Neurochem 71: 338-344. (Pubitemid 28292567)
49. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, et al. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18: 106-108.
50. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047. (Pubitemid 27443610)
51. Fortin DL, Nemani VM, Voglmaier SM, Anthony MD, Ryan TA, et al. (2005) Neural activity controls the synaptic accumulation of alpha-synuclein. J Neurosci 25: 10913-10921. (Pubitemid 41692621)
52. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, et al. (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152: 879-884. (Pubitemid 28173348)
53. Trojanowski JQ, Goedert M, Iwatsubo T, Lee VM (1998) Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. Cell Death Differ 5: 832-837. (Pubitemid 28484393)
54. Mondello S, Buki A, Italiano D, Jeromin A (2013) alpha-Synuclein in CSF of patients with severe traumatic brain injury. Neurology 80: 1662-1668.
55. Su E, Bell MJ, Wisniewski SR, Adelson PD, Janesko-Feldman KL, et al. (2010) alpha-Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia. Dev Neurosci 32: 385-395.
56. Uryu K, Giasson BI, Longhi L, Martinez D, Murray I, et al. (2003) Agedependent synuclein pathology following traumatic brain injury in mice. Exp Neurol 184: 214-224. (Pubitemid 37444032)
57. Balakathiresan N, Bhomia M, Chandran R, Chavko M, McCarron RM, et al. (2012) MicroRNA let-7i is a promising serum biomarker for blast-induced traumatic brain injury. J Neurotrauma 29: 1379-1387.
58. Dharap A, Vemuganti R (2010) Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J Neurochem 113: 1685-1691.
59. Patuzzo C, Pasquali A, Malerba G, Trabetti E, Pignatti P, et al. (2013) A Preliminary microRNA Analysis of Non Syndromic Thoracic Aortic Aneurysms. Balkan J Med Genet 15: 51-55.
60. Zhang Y, Liao Y, Wang D, He Y, Cao D, et al. (2011) Altered expression levels of miRNAs in serum as sensitive biomarkers for early diagnosis of traumatic injury. J Cell Biochem 112: 2435-2442.
61. Rau CS, Jeng JC, Jeng SF, Lu TH, Chen YC, et al. (2010) Entrapment neuropathy results in different microRNA expression patterns from denervation injury in rats. BMC Musculoskelet Disord 11: 181.
62. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, et al. (1998) Gender-linked brain injury in experimental stroke. Stroke 29: 159-165; discussion 166.
63. Soustiel JF, Palzur E, Nevo O, Thaler I, Vlodavsky E (2005) Neuroprotective anti-apoptosis effect of estrogens in traumatic brain injury. J Neurotrauma 22: 345-352. (Pubitemid 40434683)
64. Emerson CS, Headrick JP, Vink R (1993) Estrogen improves biochemical and neurologic outcome following traumatic brain injury in male rats, but not in females. Brain Res 608: 95-100. (Pubitemid 23113855)
65. Roof RL, Duvdevani R, Stein DG (1993) Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res 607: 333-336. (Pubitemid 23104985)
66. Bruce-Keller AJ, Dimayuga FO, Reed JL, Wang C, Angers R, et al. (2007) Gender and estrogen manipulation do not affect traumatic brain injury in mice. J Neurotrauma 24: 203-215. (Pubitemid 46214426)